 14. Patients with concurrent severe andor uncontrolled concurrent medical conditions that could compromise participation in the study e.g., uncontrolled diabetes mellitus defined by a glucose greater than 1.5 ULN in spite of adequate medical treatment, clinically significant pulmonary disease, clinically significant neurological disorder, active or uncontrolled infection 